When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Superdosagem de digoxina

Last reviewed: 23 Sep 2025
Last updated: 16 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • exposição à digoxina
  • sintomas gastrointestinais
  • sintomas do sistema nervoso central
  • sintomas visuais
Full details

Other diagnostic factors

  • probabilidade de suicídio
  • sintomas cardiovasculares
Full details

Risk factors

  • idade >55 anos
  • clearance renal diminuído
  • hipercalemia (>5.0 milimoles/L)
  • hipocalemia (<3.0 a 3.5 milimoles/L)
  • uso concomitante de medicamentos específicos
  • hipomagnesemia
  • hipercalcemia
  • hipotireoidismo
Full details

Diagnostic investigations

1st investigations to order

  • eletrocardiograma (ECG)
  • concentração sérica de digoxina
  • nível de potássio sérico
  • nível de magnésio sérico
  • creatinina sérica e ureia
Full details

Treatment algorithm

ACUTE

ingestão aguda, toxicidade baixa a moderada

ingestão crônica, toxicidade baixa a moderada

toxicidade grave ou comprometimento hemodinâmico (toxicidade aguda ou crônica)

ONGOING

toxicidade aguda ou crônica após início do tratamento

Contributors

Authors

Scott Phillips, MD

Associate Clinical Professor of Medicine

Department of Clinical Pharmacology and Toxicology

University of Colorado

Denver

CO

Associate Medical Director

Washington Poison Center

Seattle

WA

Disclosures

SP declares that he has no competing interests.

Acknowledgements

Dr Scott Phillips would like to gratefully acknowledge Dr Oladapo A. Odujube and Dr Robert S. Hoffman, previous contributors to this topic.

Disclosures

OAO and RSH declare that they have no competing interests.

Peer reviewers

Edward W. Boyer, MD

University of Massachusetts Medical School

Worcester

MA

Disclosures

EWB declares that he has no competing interests.

Ruben Thanacoody, MD, FRCP(Edin)

Consultant Physician and Clinical Toxicologist

National Poisons Information Service (Newcastle)

Newcastle-upon-Tyne

UK

Disclosures

RT declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006 May 30;113(21):2556-64. Abstract

Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797-800. Abstract

Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982 Nov 25;307(22):1357-62. Abstract

Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-62. Abstract

Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31(2):261-73. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Superdosagem de digoxina images
  • Differentials

    • Toxicidade por betabloqueador
    • Toxicidade por bloqueador de canais de cálcio
    • Toxicidade por clonidina
    More Differentials
  • Guidelines

    • 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay
    • Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning
    More Guidelines
  • Patient information

    Insuficiência cardíaca: como posso me ajudar?

    Insuficiência cardíaca

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer